Beese Fulmer Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$341K Buy
+882
New +$327K 0.02% 270
2026
Q1
Sell
-708
Closed -$248K 446
2025
Q4
$248K Sell
708
-117
-14% -$39.5K 0.02% 332
2025
Q3
$267K Hold
825
0.02% 250
2025
Q2
$321K Buy
+825
New +$332K 0.02% 228
2020
Q3
Sell
-34
Closed -$9K 293
2020
Q2
$9K Buy
+34
New +$9.07K ﹤0.01% 482

Other funds holding ELV

Beese Fulmer Investment Management's ELV Position: Q2 2026 in Review

Beese Fulmer Investment Management opened a new position in Elevance Health (ELV) in Q2 2026: 882 shares worth $341K. The stake represents 0.02% of the portfolio and ranks #270 among its holdings. This is a return to the name: Beese Fulmer Investment Management previously reported a position in ELV as recently as Q4 2025.

Beese Fulmer Investment Management first reported a position in ELV in Q2 2020 and has held it in 5 quarters since. 578 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Beese Fulmer Investment Management held 882 shares of Elevance Health worth $341K as of Q2 2026.
  • Elevance Health was a new Beese Fulmer Investment Management position in Q2 2026.
  • Elevance Health made up 0.02% of Beese Fulmer Investment Management's portfolio in Q2 2026, its #270 holding.
  • Beese Fulmer Investment Management first reported a position in Elevance Health in Q2 2020 and has held it in 5 quarters since.
  • 578 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Beese Fulmer Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.